Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-41.13	71.46	121.39
Graham Fair Price	43.63	8.55	5.95
PEG	-73.42	0.36	-1.35
Price/Book	24.58	5.16	4.14
Price/Cash Flow	-26.98	-210.61	-165.86
Prices/Earnings	-35.76	35.98	56.01
Price/Sales	-26.95	17.12	23.43
Price/FCF	-26.98	-210.61	-165.86
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-1.28	0.38	0.38
Operating Margin	255.90	0.18	0.05
ROA	97.28	0.02	0.01
ROE	0.02	0.04	93.92
ROIC	< 0.005	0.03	709.50
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	0.16	-97.57
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.81	5.19	537.42
EPS QOQ	-0.41	1.00	141.67
FCF QOQ	-1.35	< 0.005	99.92
Revenue QOQ	-0.38	0.74	93.96
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	157.98	73.60	-53.41
Days Sales Outstanding (DSO)	12.13	28.90	138.35
Inventory Turnover	0.57	1.22	114.65
Debt/Capitalization	0.33	0.30	-10.51
Quick Ratio	1.55	2.01	29.85
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	9.23	9.52	3.14
Cash	1.87	1.56	-16.34
Capex	-0.12	-0.13	-9.76
Free Cash Flow	-0.23	-0.23	-1.19
Revenue	1.63	2.87	75.91
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	2.99	3.40	13.71
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.18	4.24	-48.16
Naive Interpretation	Member

06 - Financial Health · Bad

Rating